Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.
Changes in the 2023 program
New schemes and products
- 2704 ACTH and cortisol
- 2706 Salivary cortisol
- 2754 Faecal elastase
- 5250 Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis
- 5261 Fungal infections, nucleic acid detection
- 5556 HSV1/HSV2/VZV/T. pallidum, nucleic acid detection
- 5965 CXCL 13 Chemokine
- 5230 Mycobacterium tuberculosis, drug resistance
- Haemoglobin, 1-level HemoCue 801 and HemoCue 301
Planned pilot schemes
Pilot schemes are EQA schemes under our product development. Read more.
All changes are listed in the Product Catalogue 2023 on page 5.
Please download the catalogue from the button below.
Subscription for 2023 will open 3 October 2022Please subscribe to the 2023 EQA programmes before the end of November 2022 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers of Labquality can renew their subscriptions on LabScala starting at 3 October 2022. If you need more information, please contact our customer service firstname.lastname@example.org.
Sales and Customer Service
External Quality Assessment
Labquality’s EQA schemes are designed for medical laboratories and point-of-care testing sites to monitor and improve their performance.
Integrated EQA Service
Integrated EQA service is a completely new approach to external quality assessment.
Labquality’s Partners in EQA
Labquality has EQA partners in more than 40 countries in Europe, South America, South-East Asia and the Middle East. Please find the contact details here.
External Quality Assessment Services
Our external quality assessment service programme includes more than 160 EQA schemes, covering the key specialities of laboratory medicine.
Labquality follows the development of laboratory medicine and produces clinically relevant EQA schemes to serve laboratories and point-of-care sites.
EQAS for preanalytical phase
Labquality’s preanalytical external quality assessment schemes provide a unique means to assess a larger part of the total laboratory testing cycle.